Statistics
Publications
32
Citations
3.1K
H-Index
21
Active since
2005
Michael Amatangelo is an author at Bristol-Myers Squibb (United States) specializing in medicine, oncology, and pharmacology.
Publications per year
2005–2024
32
32
Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers
Benjamin G. Bitler, Katherine M. Aird, Azat Garipov et al. · Nature Medicine · 2015 · 680 citations · Full text
Medicine, Cancer Biology, Oncology +16
Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response
Michael Amatangelo, Lynn Quek, Alan H. Shih et al. · Blood · 2017 · 359 citations · Full text
Medicine, Oncology, Pharmacology +12
Michael Amatangelo, Daniela Bassi, Andres J. Klein–Szanto et al. · American Journal Of Pathology · 2005 · 241 citations · Full text
Chad C. Bjorklund, Ling Lu, Jian Kang et al. · Blood Cancer Journal · 2015 · 217 citations · Full text
1–5 of 32